FDA SHOULD ALLOW POST-MARKETING SURVEY DATA IN LABELING, LILLY PREGNANCY GROUP SAYS; LILLY HAS PREGNANCY REGISTRIES FOR FOUR PRODUCTS, INCLUDING PROZAC

More from Archive

More from Pink Sheet